Birmingham, January 5, 2022 – Alveolus Bio today announced that it will be presenting virtually at the Biotech Showcase™ 2022 conference, which runs during JP Morgan Healthcare Week. With healthcare’s most important event going virtual yet again this year, registered attendees to Biotech Showcase will also get access to view presentations at their convenience if scheduling does not allow viewing during the main event.

The details of the company’s Biotech Showcase presentation are as follows:

Date: Tuesday, January 10, 2022
Time: 2:45pm. PT 
Website: Link here

Chief Executive Officer C Vivek Lal MD FAAP and Chief Operation Officer Andrew O’Connor MS MBA will share a brief overview of the inflammatory cascade that connects microbial dysbiosis to chronic lung diseases as well as expected milestones for the company’s drug development programs. 

Alveolus Bio is an emerging leader in the development of breakthrough biotherapeutics for respiratory disease. The company has built a strong pipeline in live biotherapeutics and small molecule-based therapies for inflammatory lung diseases, leveraging its proprietary resMIT® technology to develop inhaled microbiota-based therapies. Currently, Alveolus Bio has three assets in the pre-IND stage which respectively target COPD, IPF, and neutrophilic asthma.

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference typically takes place in San Francisco, but recently moved to go virtual for the second year in a row.

“We are delighted that Alveolus Bio will be presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”


Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 14th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.


Alveolus Bio is a team of scientists, physicians, and innovators pioneering breakthrough FDA-approved therapeutics for lung diseases. The Alveolus pipeline includes preclinical phase biotherapeutics for Chronic Obstructive Pulmonary Disease (COPD), and Idiopathic Pulmonary Fibrosis (IPF), Neutrophilic Asthma, Pulmonary Arterial Hypertension (PAH), and Acute Respiratory Distress Syndrome (ARDS).

Follow Alveolus Bio on Twitter at @AlveolusBio and Biotech Showcase at @EBDGroup and @Demy_Colton and tag your posts with #BiotechShowcase.